TrialBMC cancer2015

Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.

Yoshito Komatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.